Company Filing History:
Years Active: 1999
Title: Matheus Hubertus Noteborm: Innovator in Viral Vaccines
Introduction
Matheus Hubertus Noteborm is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of virology, particularly in the development of vaccines against the Chicken Anemia Virus (CAV). His innovative work has implications for both animal health and the broader field of immunology.
Latest Patents
Noteborm holds a patent for "Chicken anemia virus mutants and vaccines and uses based on the viral." This patent describes novel proteins of the Chicken Anemia Virus and compositions aimed at preventing or treating infections caused by this virus. The invention focuses on vaccines that are less pathogenic than the CAV itself, yet capable of inducing neutralizing antibodies in immunized animals. Additionally, it includes compositions containing antibodies against parts of the CAV for infection control, as well as anti-idiotype antibodies. The patent also encompasses antibodies and test kits for the detection of CAV, recombinant DNA molecules derived from CAV, and vaccines based on host cells transfected with these molecules. Furthermore, it provides methods for inducing apoptosis in tumor cells and cell death through gene therapy.
Career Highlights
Matheus Hubertus Noteborm is associated with Leadd B.V., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the understanding of viral infections and the development of effective vaccines.
Collaborations
Noteborm collaborates with Guus Koch, contributing to the innovative research in the field of virology and vaccine development.
Conclusion
Matheus Hubertus Noteborm's contributions to the field of viral vaccines, particularly against the Chicken Anemia Virus, highlight his role as a significant inventor in the realm of immunology. His innovative approaches and collaborations continue to pave the way for advancements in vaccine technology.